Brief introduction:An adjunct to chemotherapy agents to extend survival and to maintain remission after treatment for acute non-lymphocytic leukemia in adults.
Brief introduction:Deemed to have completed the Quality Consistency Evaluation; It is indicated as a single agent for adjuvant treatment in patients with Dukes' C colon cancer,and for treatment of patients with metastatic colorectal carcinoma, metastatic breast cancer, advanced or metastatic gastric cancer and combined adjuvant treatment after an operation (see Package Leaflet for details).
Tel +86-28-87827187; E-mail: sales@eastonpharma.cn
API business
Factory: Sichuan Qingmu Pharmaceutical Co., Ltd
Add: No.55, South Shunjiang Avenue, East Economic Development Zone, Meishan City, Sichuan, 612100, China
Sales/Marketing/BD/CDMO: Tel +86-28-87827187;
E-mail: sales@eastonpharma.cn
Human Resources
Headquarter: No.8, Ankang Road, Tianfu International Bio-town, Shuangliu District, Chengdu, 610200, China
Hi-tech factory: No.8, Xiyuan Ave., Hi-tech District, Chengdu, 611731, China
Email: hr@eastonpharma.cn
This website does not publish the product information of narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug rehabilitation drugs and preparations of medical institutions.|
Copyright ? 成都苑東生物制藥股份有限公司 ALL Rights Reserved互聯(lián)網(wǎng)藥品信息服務(wù)資格證編號(hào):(川)-非經(jīng)營(yíng)性-2021-0036